Used as an intermediate in the synthesis of potent kinase inhibitors, particularly in the development of anticancer agents. Its structure enables selective binding to specific protein targets involved in cell signaling pathways, making it valuable in pharmaceutical research for targeted therapies. The compound's fluorinated aromatic systems enhance binding affinity and metabolic stability, which are critical for oral bioavailability and efficacy in vivo. It is primarily employed in late-stage drug discovery for optimizing lead compounds with improved pharmacokinetic profiles.